Skip to main content
Fig. 4 | Fluids and Barriers of the CNS

Fig. 4

From: Role of interleukin-6 and interleukin-10 in morphological and functional changes of the blood–brain barrier in hypertriglyceridemia

Fig. 4

Changes in wild type (WT) and apolipoprotein B-100 (APOB-100) glial cell densities following cytokine treatments. Effects of IL-6, IL-10 and IL-6 + IL-10 cytokine treatments in primary glial cell cultures isolated from WT and APOB-100 transgenic mice on a astroglia density immunostained for GFAP, b microglia density immunostained for Iba-1, c astroglia/microglia ratio. #: significant change between WT and APOB-100 cells (p < 0.05); *: significant change due to cytokine treatment compared to the control group with the same genotype (p < 0.05)

Back to article page

Fluids and Barriers of the CNS

ISSN: 2045-8118